285 related articles for article (PubMed ID: 3126290)
1. Mechanisms of corneal drug penetration. I: In vivo and in vitro kinetics.
Grass GM; Robinson JR
J Pharm Sci; 1988 Jan; 77(1):3-14. PubMed ID: 3126290
[TBL] [Abstract][Full Text] [Related]
2. Effects of calcium chelating agents on corneal permeability.
Grass GM; Wood RW; Robinson JR
Invest Ophthalmol Vis Sci; 1985 Jan; 26(1):110-3. PubMed ID: 3917988
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of corneal drug penetration. II: Ultrastructural analysis of potential pathways for drug movement.
Grass GM; Robinson JR
J Pharm Sci; 1988 Jan; 77(1):15-23. PubMed ID: 3346818
[TBL] [Abstract][Full Text] [Related]
4. Relationship of chemical structure to corneal penetration and influence of low-viscosity solution on ocular bioavailability.
Grass GM; Robinson JR
J Pharm Sci; 1984 Aug; 73(8):1021-7. PubMed ID: 6491903
[TBL] [Abstract][Full Text] [Related]
5. Ocular absorption of Pz-peptide and its effect on the ocular and systemic pharmacokinetics of topically applied drugs in the rabbit.
Chung YB; Han K; Nishiura A; Lee VH
Pharm Res; 1998 Dec; 15(12):1882-7. PubMed ID: 9892473
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of corneal drug penetration. III: Modeling of molecular transport.
Grass GM; Cooper ER; Robinson JR
J Pharm Sci; 1988 Jan; 77(1):24-6. PubMed ID: 3346819
[TBL] [Abstract][Full Text] [Related]
7. Ocular membrane permeability of hydrophilic drugs for ocular peptide delivery.
Sasaki H; Ichikawa M; Yamamura K; Nishida K; Nakamura J
J Pharm Pharmacol; 1997 Feb; 49(2):135-9. PubMed ID: 9055183
[TBL] [Abstract][Full Text] [Related]
8. Corneal and conjunctival drug permeability: Systematic comparison and pharmacokinetic impact in the eye.
Ramsay E; Del Amo EM; Toropainen E; Tengvall-Unadike U; Ranta VP; Urtti A; Ruponen M
Eur J Pharm Sci; 2018 Jul; 119():83-89. PubMed ID: 29625211
[TBL] [Abstract][Full Text] [Related]
9. Corneal penetration behavior of beta-blocking agents II: Assessment of barrier contributions.
Huang HS; Schoenwald RD; Lach JL
J Pharm Sci; 1983 Nov; 72(11):1272-9. PubMed ID: 6139472
[TBL] [Abstract][Full Text] [Related]
10. Modification of ocular permeability of peptide drugs by absorption promoters.
Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
Biol Pharm Bull; 2000 Dec; 23(12):1524-7. PubMed ID: 11145191
[TBL] [Abstract][Full Text] [Related]
11. Corneal critical barrier against the penetration of dexamethasone and lomefloxacin hydrochloride: evaluation by the activation energy for drug partition and diffusion in cornea.
Yasueda S; Higashiyama M; Yamaguchi M; Isowaki A; Ohtori A
Drug Dev Ind Pharm; 2007 Aug; 33(8):805-11. PubMed ID: 17729097
[TBL] [Abstract][Full Text] [Related]
12. Ocular permeability of FITC-dextran with absorption promoter for ocular delivery of peptide drug.
Sasaki H; Yamamura K; Tei C; Nishida K; Nakamura J
J Drug Target; 1995; 3(2):129-35. PubMed ID: 7496726
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of EDTA and boric acid on corneal penetration of CS-088.
Kikuchi T; Suzuki M; Kusai A; Iseki K; Sasaki H
Int J Pharm; 2005 Feb; 290(1-2):83-9. PubMed ID: 15664133
[TBL] [Abstract][Full Text] [Related]
14. Ocular disposition of topically applied histamine, cimetidine, and pyrilamine in the albino rabbit.
Hui HW; Zeleznick L; Robinson JR
Curr Eye Res; 1984 Feb; 3(2):321-30. PubMed ID: 6705556
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of permeability-enhancing effect of EDTA and boric acid on the corneal penetration of 4-[1-hydroxy-1-methylethyl]-2-propyl-1-[4-[2-[tetrazole-5-yl]phenyl]phenyl] methylimidazole-5-carboxylic acid monohydrate (CS-088).
Kikuchi T; Suzuki M; Kusai A; Iseki K; Sasaki H; Nakashima K
Int J Pharm; 2005 Aug; 299(1-2):107-14. PubMed ID: 15979832
[TBL] [Abstract][Full Text] [Related]
16. Topical carbonic anhydrase inhibitors IV: Relationship between excised corneal permeability and pharmacokinetic factors.
Eller MG; Schoenwald RD; Dixson JA; Segarra T; Barfknecht CF
J Pharm Sci; 1985 May; 74(5):525-9. PubMed ID: 4020628
[TBL] [Abstract][Full Text] [Related]
17. Effect of acylation on the ocular disposition of acyclovir. II: Corneal permeability and anti-HSV 1 activity of 2'-esters in rabbit epithelial keratitis.
Hughes PM; Mitra AK
J Ocul Pharmacol; 1993; 9(4):299-309. PubMed ID: 8106836
[TBL] [Abstract][Full Text] [Related]
18. Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbits.
Zhang J; Wang L; Gao C; Zhang L; Xia H
J Ocul Pharmacol Ther; 2008 Oct; 24(5):501-6. PubMed ID: 18803444
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics of topically applied fluconazole in the rabbit eye].
Zhang J; Xie L; Chen Z; Zhang Q
Zhonghua Yan Ke Za Zhi; 2002 Feb; 38(2):108-11. PubMed ID: 11955312
[TBL] [Abstract][Full Text] [Related]
20. Expression of multidrug resistance associated protein 5 (MRP5) on cornea and its role in drug efflux.
Karla PK; Quinn TL; Herndon BL; Thomas P; Pal D; Mitra A
J Ocul Pharmacol Ther; 2009 Apr; 25(2):121-32. PubMed ID: 19323627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
